Dose Finding in Drug Development -
-20% with code BOOKS
Shipping in 12-18 days
30-day return policy
This book emphasizes dose selection issues from a statistical point of view. It presentsstatisticalapplicationsinthedesignandanalysisofdose¿responsestudies. The importance of this subject can be found from the International Conference on Harmonization (ICH) E4 Guidance document. Establishing the dose¿response relationship is one of the most important act- ities in developing a new drug. A clinical developme ... Full description
You May Also Like
TOP
The Myth of Normal: Trauma, Illness, and Healing in a Toxic Culture
-20% with code BOOKS
In stock
TOP
Lifespan: Why We Age - and Why We Don't Have To
-20% with code BOOKS
In stock at our supplier
TOP
On Connection: 'Powerful' MATT HAIG
-20% with code BOOKS
In stock at our supplier
TOP
Harrison's Principles of Internal Medicine (Vol.1 & Vol.2)
Stephen Hauser, Joseph Loscalzo, Steven Holland, Dan Longo, J. Larry Jameson, Dennis Kasper, Carol Langford, Anthony Fauci
-20% with code BOOKS
In stock at our supplier
TOP
The Body Keeps the Score: Brain, Mind, and Body in the Healing of Trauma
-20% with code BOOKS
In stock at our supplier
TOP
No Bad Parts: Healing Trauma and Restoring Wholeness with the Internal Family Systems Model
-20% with code BOOKS
In stock at our supplier
TOP
Oxford Handbook of Anaesthesia
-20% with code BOOKS
In stock at our supplier
TOP
Maybe You Should Talk to Someone: a therapist, her thearapist, and our lives revealed
-20% with code BOOKS
In stock at our supplier
TOP
Unlearn Your Pain: The Science of Recovering from Chronic Pain, Fatigue, Anxiety, and Depression
-20% with code BOOKS
In stock at our supplier
TOP
The Checklist Manifesto: How to Get Things Right
-20% with code BOOKS
In stock at our supplier
TOP
Attached: Are you Anxious, Avoidant or Secure? How the science of adult attachment can help you find - and keep - love
Amir Levine, Rachel S.F. Heller
-20% with code BOOKS
In stock at our supplier
TOP
Cellular and Molecular Immunology
Sarah Henrickson, Abul K. Abbas, Andrew H. Lichtman, Shiv Pillai
-20% with code BOOKS
In stock at our supplier
TOP
The Autistic Burnout Workbook: Your Guide to Your Personal Recovery Plan
-20% with code BOOKS
In stock at our supplier
TOP
Anatomy of the Horse: with Aaron Horowitz and Rolf Berg
Klaus-Dieter Budras, W. O. Sack, Sabine Röck
-20% with code BOOKS
In stock at our supplier
TOP
Physics, Pharmacology and Physiology for Anaesthetists: Key Concepts for the FRCA
Matthew E. Cross, Emma V. E. Plunkett
-20% with code BOOKS
In stock at our supplier
TOP
Oxford Handbook of Clinical Medicine
Peter Hateley, Iain McGurgan, Ian B. Wilkinson, Tim Raine, Dearbhla Kelly, Kate Wiles
-20% with code BOOKS
In stock at our supplier
TOP
Pocket Guide to Teaching for Clinical Instructors
-20% with code BOOKS
In stock at our supplier
TOP
Oxford Handbook of Critical Care
Andrew Webb, Mervyn Singer, Alice Carter
-20% with code BOOKS
In stock at our supplier
TOP
The Wills Eye Manual: Print + eBook with Multimedia: Office and Emergency Room Diagnosis and Treatment of Eye Disease
-20% with code BOOKS
In stock at our supplier
Description
This book emphasizes dose selection issues from a statistical point of view. It presentsstatisticalapplicationsinthedesignandanalysisofdose¿responsestudies. The importance of this subject can be found from the International Conference on Harmonization (ICH) E4 Guidance document. Establishing the dose¿response relationship is one of the most important act- ities in developing a new drug. A clinical development program for a new drug can be broadly divided into four phases ¿ namely Phases I, II, III, and IV. Phase I clinical trials are designed to study the clinical pharmacology. Information - tained from these studies will help in designing Phase II studies. Dose¿response relationshipsareusuallystudiedinPhaseII.PhaseIIIclinicaltrialsarelarge-scale, long-term studies. These studies serve to con?rm ?ndings from Phases I and II. ResultsobtainedfromPhasesI,II,andIIIclinicaltrialswouldthenbedocumented and submitted to regulatory agencies for drug approval. In the United States, - viewers from Food and Drug Administration (FDA) review these documents and make a decision to approve or to reject this New Drug Application (NDA). If the new drug is approved, then Phase IV studies can be started. Phase IV clinical trials are also known as postmarketing studies.
More Information
| Publisher | Springer US |
|---|---|
| Series | Statistics for Biology and Health |
| Release year | 2010 |
| Cover type | Softcover |
| EAN | 9781441921154 |